CD45 (PTPRC) as a candidate gene in multiple sclerosis

Multiple Sclerosis

Volumn 10, Issue 6, 2004, Pages 614-617

  Vyshkina, Tamara ^a   Leist, Thomas P ^b   Shugart, Yin Yao ^c   Kalman, Bernadette ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

CD45; Genetics; Multiple sclerosis

Indexed keywords

CD45 ANTIGEN; CYSTEINE; GLYCINE;

ALLELE; AMINO ACID SUBSTITUTION; ARTICLE; COMPUTER PROGRAM; EXON; FAMILY; GENE FUNCTION; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; HETEROZYGOTE; HETEROZYGOTE DETECTION; HUMAN; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; PEDIGREE; PROGENY; SINGLE NUCLEOTIDE POLYMORPHISM; VERTICAL TRANSMISSION;

ANTIGENS, CD45; EXONS; FAMILY HEALTH; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MULTIPLE SCLEROSIS; PEDIGREE; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 9744229937     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1191/1352458504ms1115oa     Document Type: Article

References (14)

1. Jacobsen M, Schweer D, Ziegler A, Gaber R, Schock S, Schwinzer R et al. A point mutation in PTPRC is associated with the development of multiple sclerosis. Nat Genet 2000; 26: 495-99.
2. Ballerini C, Rosati E, Salvetti M, Ristori G, Cannoni S, Biagioli T et al. Protein tyrosine phosphatase receptor-type C exon 4 gene mutation distribution in an Italian multiple sclerosis population. Neurosci Lett 2002; 328: 325-27.
3. Barcellos LF, Caillier S, Dragone L, Elder M, Vittinghoff E, Bucher P et al. PTPRC (CD45) is not associated with the development of multiple sclerosis in US patients. Nat Genet 2001; 29: 23-24.
4. Miterski B, Sindern E, Haupts M, Schimrigk S, Epplen JT. PTPRC (CD45) is not associated with multiple sclerosis in a large cohort of German patients. BMC Med Genet 2002; 3: 3.
5. Vorechovsky I, Kralovicova J, Tchilian E, Masterman T, Zhang Z, Ferry B et al. Does 77C → G in PTPRC modify autoimmune disorders linked to the major histocompatibility locus? Nat Genet 2001; 29: 22-23.
6. Nicholas RS, Partridge J, Donn RP, Hawkins C, Boggild MD. The role of the PTPRC (CD45) mutation in the development of the multiple sclerosis in the North West region of the United Kingdom. J Neurol Neurosurg Psychiatry 2003: 74: 944-45.
7. Gomez-Lira M, Liguori M, Magnani C, Bonamini D, Salviati A, Leone M et al. CD45 and multiple sclerosis: the exon 4 C77G polymorphism (additional studies and meta-analysis) and new markers. J Neuroimmunol 2003; 140: 216-21.
8. Tackenberg B, Nitschke M, Willcox N, Ziegler A, Nessler S, Schumm F et al. CD45 isoform expression in autoimmune myasthenia gravis. Autoimmunity 2003; 36: 117-21.
9. Schwinzer R, Witte T, Hundrieser J, Ehlers S, Momot T, Hunzelmann N et al. Enhanced frequency of a PTPRC (CD45) exon A mutation (77C → G) in systemic sclerosis. Genes and Immunity 2003; 4: 168-69.
10. Vogel A, Strassburg CP, Manns MP. 77C → G mutation in the tyrosine phosphatase CD45 gene and autoimmune hepatitis: evidence for a genetic link. Genes and Immunity 2003; 4: 79-81.
11. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983; 13: 227-31.
12. Martin ER, Monks SA, Warren LL, Kaplan NL. A test for linkage and association in general pedigrees: the pedigree disequilibrium test. Am J Hum Genet 2000; 67: 146-54.
13. Spielman RS, McGinnis RE, Ewens WJ. Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 1993; 52: 506-16.
14. Clayton D. A generalization of the transmission/disequilibrium test for uncertain-haplotype transmission. Am J Hum Genet 1999; 65: 1170-77.